Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study

By Barake Maya   Evins A.   Stoeckel Luke   Pachas Gladys   Nachtigall Lisa   Miller Karen   Biller Beverly   Tritos Nicholas   Klibanski Anne  

Pituitary, Vol. 17, Iss. 2, 2014-04 ,pp. : 150-156

Springer Publishing Company

Access to resources Recommend Favorite

Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection

By Sughrue Michael   Chang Edward   Tyrell J.   Kunwar Sandeep   Wilson Charles   Blevins Lewis  

Pituitary, Vol. 12, Iss. 3, 2009-09 ,pp. : 158-164

Springer Publishing Company

Access to resources Recommend Favorite

Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy

By Giusti M.   Fazzuoli L.   Cavallero D.   Valenti S.  

Gynecological Endocrinology, Vol. 16, Iss. 5, 2002-10 ,pp. : 407-412

Informa Healthcare

Access to resources Recommend Favorite

Is Dopamine Agonist Therapy Associated with Developing Pathological Gambling in Parkinson’s Disease Patients?

By  

European Neurology, Vol. 59, Iss. 3-4, 2008-01 ,pp. : 183-186

Karger

Access to resources Recommend Favorite

Early Motor Fluctuations in a Patient with Striatonigral Degeneration

By  

Case Reports in Neurology, Vol. 8, Iss. 3, 2016-12 ,pp. : 243-250

Karger

Access to resources Recommend Favorite